Mesosil

Mesosil has developed a proprietary platform technology to manufacture responsive silica-based biomaterials that can be incorporated as slow-release and long-lasting antimicrobial additives into biomedical devices. Current treatment failure leads to provider-patient churn, incurring additional costs for patients and do

Mesosil operates in matter.

Profile

Mesosil has developed a proprietary platform technology to manufacture responsive silica-based biomaterials that can be incorporated as slow-release and long-lasting antimicrobial additives into biomedical devices. Current treatment failure leads to provider-patient churn, incurring additional costs for patients and doctors and increasing the incidence of inflammation and pain in patients. Mesosil biomaterials enhance the longevity of […]

As a business in matter, Mesosil is listed here with the public details available about it.

Its current recorded stage is Creative Destruction Lab alumni company.

Website: www.mesosil.com